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The Effects of Drugs, Other Foreign
Compounds, and Cigarette Smoke on the
Synthesis of Protein by Lung Slices
by K. Hellstern,* C. G. Curtis,* D. G. Upshall,t
and G. M. Powell*
The incorporation of "4C-leucine into rabbit lung slices was monitored in the absence and presence
ofselected drugs and chemicals relevant to the perturbation oflung function and the development of
lungdisease. Knowninhibitors ofproteinsynthesis (cycloheximideandricin) inhibitedtheincorpora-
tionof"4C-leucine. Markedinhibitionwasalsorecordedwiththelungtoxinsparaquatand4-ipomeanol.
By contrast, orciprenaline, salbutamol, andterbutaline were without effect although some response
wasrecordedwithisoprenaline. Thefilteredgasphaseofcigarette smokeandacrolein, one ofits com-
ponents, were inhibitory but protection was afforded by N-acetylcysteine. It is suggested that the
inhibitory effects ofcigarette smoke may be due to its acrolein content. It is further suggested that
theuseoflungslicesandmeasurements of14C-leucineincorporationprovidevaluablemeansformonitor-
ing potential pulmonary toxins.
Introduction
The chemicalchallenge tothe lungsby airborne com-
poundsandagentsisformidable, andthecapabilityand
capacity of pulmonary tissue in the detoxication of
noxious chemicals has been extensively investigated
(1,2). It is also well known that the lung is particularly
vulnerable tocertaintoxicchemicals. Forexample, para-
quat (3) and 4-ipomeanol (4,5) are known to cause par-
ticularly severe and specific damage to lung tissue.
Althoughthe eventual response tovarioustoxic chemi-
cals in terms ofpulmonary disease hasbeen described,
much remains to be learned about cellular metabolic
activity and overall lung function and the mechanisms
bywhichintermediary metabolismisalteredindisease.
Itmightbeexpectedthatperturbationsofpulmonary
intermediary metabolism caused by noxious chemicals
would be reflected in the relative efficiencies of the
defense mechanisms. This study seeks to investigate
those perturbations and to design a model system for
monitoring the initial effects of various chemicals on
the lung.
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The synthesis of protein by the lung was studied in
the presence of selected drugs and chemicals that are
known to be pertinent to lung function and to lung
disease. Protein biosynthesis was chosen as an indi-
cator ofinitialtoxiceffectbecausetheformationofpro-
teinrequirestheintegrationandcooperationofthemany
pathways culminating in amino acid assembly. Altera-
tions in the rates of any one of those pathways would
be reflected in the rate of protein biosynthesis.
Arangeofcompoundswasstudied, andincludedthose
known to cause pulmonary conditions such as edema,
fibrosis, and hemorrhage; and several bronchiodilators
normally administered directly to the lungs by inhala-
tion. TheseincludedtheselectiveP2-adrenoceptorstim-
ulants salbutamol and terbutaline, the nonselective
P-adrenoceptor stimulants isoprenaline and orciprena-
line, andthecorticosteroidbetamethasone. Inaddition,
the effects were studied of the filtered gas phase of
cigarette smoke and acrolein, one of its components.
Materials and Methods
Chemicals
[U'4C]Leucine(37mCi/mmole), PCSscintillationfluid,
and a NCS tissue solubilizer were purchased from the
Radiochemical Centre (Amersham, Bucks, UK).HELLSTERNETAL.
MEM Eagles medium waspurchased from Gibco Ltd.
(Paisley, Scotland); ricinandN-acetylcysteinefromSigma
ChemicalCo. (Poole, Dorset, UK); paraquatfromAldrich
ChemicalCo. Ltd. (Gillingham, Dorset, UK); andacrolein
from Fluka AG (Chemische Fabrik CH-9470 Buchs).
Salbutamol, isoprenaline, terbutaline, orciprenaline,
betamethasone sodium phosphate (Becotide), bleo-
mycin, and cycloheximide were obtained from Dr. B.
Evans (Department of Pharmacy, University of Wales
College ofMedicine, UK)and4-ipomeanolwasagiftfrom
M. R. Boyd (National Cancer Institute, MD). All other
chemicals were obtained from British Drug Houses
(Poole, Dorset, UK).
Cigarette Smoke
Freshlydrawnfilteredcigarettesmokewasusedinall
experiments and was prepared as described by Green
and Carolin (6). Filter tips were removed from the
cigarettes before smoking. Aqueous extracts of the
filtered gas phase of cigarette smoke were prepared in
modified Krebs-Ringer phosphate medium by drawing
25 mL portions ofsmoke into syringes containing 1 mL
of the medium.
Animals
MatureNewZealandWhite rabbits(2.5-3.5kg)main-
tained onastandarddiet(rabbitpellets, Pilsbury'sLtd.,
Priory Road, Edgbaston, Birmingham, UK) were used
throughout.
Preparation of Lung Slices
Rabbitswereanesthetized withSagatal(60mg/kg)ad-
ministered via the marginal ear vein. Heparin (1000
units/kg) was then injected. Following a midline ab-
dominal incision, animals were exsanguinated by can-
nulation of the abdominal aorta toward the heart. The
thoracic cavity was opened after the diaphragm had
been punctured, and a cannula was inserted into the
pulmonary artery via the left auricle and secured with
a ligature. Isotonic saline (0.9% wv,- 50 mL at 370C)
wastheninfused, andtheheartwasincisedtoallowex-
it ofthe saline solution. The trachea was then isolated,
clamped, andtheheart-lungpreparation wasremoved.
The preparation was washed briefly with warm (37°C)
isotonicsaline, andtheheart, togetherwithothertissue,
was dissected from the lungsthat were then washed in
phosphate-buffered saline(137mMNaCl, 2.68mMKCl,
8.1 mMNa2HPO4, 1.47mMKH2PO4, pH7.4, at4°C). The
trachea was removed and lung slices (-0.5 mm), cut
manuallyusingarazorbladeonacooled(4°C)glassplate,
were placed in phosphate-buffered saline (40C).
Measurement of Protein Production
by Lung Slices
Lungslices(-250 mgwetwt) were rinsed in the incu-
bation medium [1 vol of MEM Eagles medium: 9 vol
of water: 10 vol of phosphate-buffered saline, 0.5 mM
ascorbic acid, adjusted to pH 7.4 (with NaHCO3, 4.4%
w/v) and equilibrated with a gas mixture (95% 02/5%
C02)]. The slices were incubated for two successive
periods (preincubation and incubation periods). In the
preincubation period, slices were incubated in vessels
containing 1 mL ofthe gassed medium and maintained
at 37°C for 45 min. The vessels were shaken.
Inallexperimentsexceptforsomewithricin, thecom-
pounds under investigation were present in the pre-
incubationperiodonly. Inexperimentsusingthefiltered
gas phase of cigarette smoke, lung slices were prein-
cubated with 1 mL of a modified Krebs-Ringers phos-
phate medium containing the smoke and prepared' as
described previously.
After the preincubation period, the medium was
aspirated and discarded, and fresh medium (1 mL) con-
taining 14C-leucine(0.2 ,uCi/mL)wasadded. Vesselswere
thengassedwithanoxygen-carbondioxidemixture(95:5
v/v) and incubated at 370C, with shaking, for periods
rangingfrom 15minto3hr. Attheendoftheincubation
period the lung slices were separated from media by
vacuum-assistedfilteringandrinsed(3timeswith 10mL
phosphate-buffered salineat4°C). Lungsliceswerethen
homogenized (Tri-R instrument, Rockville Center, NY)
in 2.5 mL of phosphate-buffered saline and perchloric
acid(0.5mL, 1 M)wasaddedimmediately. After30min
at room temperature the homogenates were centri-
fuged (600g for 20 min). Pellets were resuspended in
2 mLofwaterand0.5 mLof 1 M perchloric acid follow-
ed by centrifugation (600g for 20 min). This procedure
was repeated three times, and the pellets were then
resuspended in 1 mLofmethanolfollowedbycentrifug-
ing(600g for 10 min). Supernatants were removed and
pelletsweredriedat50°Cfor 16hr. Eachpelletwasthen
crushedanddividedintotwoportions. Oneportionwas
assayed for protein contentby the method of Lowry et
al. (7) usingbovine serum albumin asthestandard. The
other portion was used for assaying the incorporation
of '4C-leucine. It was incubated at 50°C for 4 hr with 1
mLofNCStissuesolubilizer. Aftercooling, solutionswere
bleachedbyadding0.6mLofH202(30%, w/v)in0.2 mL
portions and 0.2 mL propan-2-ol. Solutions were then
heated (500C) for 10 min, and after cooling they were
storedinthedarkfor 16hr. Glacialaceticacid(1 mL)and
PCS(15 mL) were added to each sample, and the radio-
active contents were determined by liquid scintillation
counting (LKB 1217 Rackbeta liquid scintillation
counter).
Results
Measurement of Protein Production
by Lung Slices in the Presence of
Foreign Compounds
In mostexperiments test compounds were present in
the preincubation period only. However, in some
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experiments theywerepresentintheincubationperiod
or in both the preincubation and incubation periods.
In initial experiments the rate of protein production
wasmeasured inlungslicesundercontrol conditionsin
theabsence ofpotentialtoxins. Afteraninitiallagphase
of approximately 10 to 15 min, there was linear incor-
porationofradioactivityintoprotein, andthiswasmain-
tained over 3 hr. Incorporation rates ranged from 2.22
X 10-4 .tCi/mg protein/3 hr to 22.2 x 10-4 jjCi/mg
protein/3 hr in 35 separate experiments; in 70% of the
experiments the incorporation rate was in the range
3 to 7 x 10-4 uCi/mg protein/3 hr. In all experiments in
whichthe effects ofpotentialtoxinswere assessed, the
ratesofincorporation ofradioactivity inthe absence of
toxins were also measured.
The experimental system was tested in the presence
of known inhibitors of protein synthesis, namely,
cycloheximideandricin. Lungsliceswereincubatedwith
cycloheximide at two concentrations (0.5 and 1 g/mM
duringthepreincubationperiodonly). Itwasshownthat
proteinsynthesiswasinhibited almostcompletely, with
the incorporation of l4C-leucine reducedto 3.2% ofthe
control value at both concentrations of cycloheximide.
Protein synthesis was also severely inhibited
by ricin. The effect of ricin at two concentrations
(4 /ig/mg/mL and 10jimL)added tolungslicesafterthe
preincubationperiodisillustratedinFigure 1. Therates
of incorporation of '4C-leucine in the presence of ricin
were identical to controls until 1 hr of incubation, but
thereafter there was virtually no incorporation.
Inotherexperiments, ricinatthesameconcentrations
(4 and 10,ug/mL) was present duringthe preincubation
period only. Test and control 14C incorporation figures
werevirtuallyindistinguishable after30minofincuba-
tion, but thereafter-although protein production pro-
ceededinthepresenceofricinandtheratewaslinear-it
was reduced to approximately 20% of the control rate
at both concentrations of inhibitor. The results of ex-
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FIGURE 1. Incorporation of '4C-leucine into proteinbylungslicesin
the absence of toxin (e) and in the presence of ricin at two con-
centrations, 4 pg/mL(A) and 10jAg/mL(U). Ricin was present in
the incubation period only, i.e., added at time zero. Each point
represents the mean of two determinations.
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FIGURE 2. The effect ofricinconcentration onthe incorporation of
'4C-leucine intoproteinover3 hr. Thericinwaspresentinthepre-
incubation period only. Each point represents the mean of two
determinations. Range values are shown by vertical lines.
periments in which the incorporation of 14C was
measured in the presence of various concentrations of
ricin present during the preincubation period only are
shown in Figure 2 and demonstrate that the inhibition
is dose related.
Experiments with Selected Drugs
Intheseexperimentstheconcentrationsofdrugswere
based on clinical dose regimes. Thus, the nonselective
P-receptor stimulants isoprenaline and orciprenaline
were incubated with lung slices at concentrations
ranging from 0.074 to 0.93 mM and 0.11 to 10.60 mM,
respectively. Some inhibition(Table 1)of14C-leucine in-
corporation was recorded with isoprenaline at higher
concentrations, butwithorciprenalinetherateofincor-
poration was higher than control values at all concen-
trationsofthedrug. Theresultsobtainedwiththemore
selective p2-receptor stimulants terbutaline and
salbutamol are also shown in Thble 1; it is evident that
neitherdrugaffected significantlythe incorporationof
14C-leucine. Whenthe corticosteroid betamethasone was
present inlungslice incubates, abiphasicresponse was
noted. Thus, whenthedrugwaspresentathigh concen-
trations (0.81 mM and 0.62 mM) incorporation was in-
hibitedbyapproximately50%, whereasataconcentra-
tion of0.11 mM there was stimulation of "4C incorpora-
tion by 66%.
Experiments with Pulmonary Toxins
The effects on protein synthesis of the established
pulmonary toxins paraquat and 4-ipomeanol were
measured at the concentration ranges of0.1 to 1.0 mM
and0.06 to 0.65 mM, respectively. Inhibition ofprotein
synthesis wasrecordedatallconcentrationsofthecom-
pounds and the inhibition was dose related (Fig. 3).
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Table 1. The effects of some bronchodilatory drugs on the
incorporation of '4C-leucine into protein in lung slices.a
Incorporation of '4C-leucine
Concentration, into lung protein over 3 hr,
Drug mM % of control
Isoprenaline 0.93 85
0.67 84
0.37 96
0.22 84
0.074 108
Orciprenaline 10.60 112
5.30 115
2.10 129
0.53 114
0.11 142
Terbutaline 4.39 99
2.63 125
1.00 104
0.20 135
0.10 110
Salbutamol 4.34 109
0.09 112
Betamethasone 0.81 48
0.62 48
0.43 76
0.22 120
aEach figure is the average of two separate incubations.
Experiments with Cigarette Smoke
and Acrolein
Inallexperimentstheincorporation of14C-leucine was
inhibited by aqueous extracts of the filtered gas phase
(25 mL or 50 mL) of cigarette smoke. The results of a
typical experiment in which incorporation was greatly
reduced in the presence of50 mL ofsmoke is shown in
Figure 4. Protection from the effects ofsmoke was pro-
videdwhenN-acetylcysteine (0.7mM) wasincorporated
into the medium before exposure to smoke (Fig. 4).
The effect of acrolein on the incorporation of
14C-leucine over 3 hr was measured at acrolein concen-
trations ranging from 0.038 mM to 0.38 mM. In all
experiments a biphasic response was recorded as
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FIGURE 3. The effect of paraquat (0) and 4-ipomeanol (U) on the
incorporation of '4C-leucine into protein over 3 hr. Toxins were
present in the preincubation period only. Each point represents
the mean of two determinations (no range, but present on other
graphs, e.g., Figs. 2-5).
80 V 0
60J 00
40-
0
20
0 50
Smoke Volume (ml)
FIGURE 4. The effect ofthe filtered gasphase ofcigarette smoke on
theinicorporationof'4C-leucineintoproteinover3hrintheabsence
(D)and presence(71)ofN-acetylcysteine (0.7mM). Smoke and/or
N-acetylcysteine were present in the preincubation period only.
Each value is the mean of two determinations. Range values are
shown by vertical lines.
illustrated in Figure 5. At concentrations of 0.038
mM and0.076mMtherewereslightincreasesintherates
ofincorporation, butathigherconcentrationstheincor-
poration was markedly inhibited. Further time-course
studies(Fig. 6)withinhibitoryconcentrationsofacrolein
(0.17 mM, 0.36 mM, and 0.89 mM) demonstrated that
although the incorporation of 14C-leucine was marked-
lyreducedateachconcentration, theincorporationrates
werelinear. Withacroleinat0.89mM, inhibitionwasvir-
tually complete.
Further experiments with acrolein were carried out
in which 14C-leucine incorporation was measured over
3 hr in lung slices incubated with acrolein at two con-
centrations (0.21 mM and 0.36 mM) in the absence and
presence of N-acetylcysteine (0.7 mM) (Fig. 7). The
incorporation of 14C-leucine was inhibited by 31% and
63%, respectively, butnoinhibitionwasrecordedwhen
N-acetylcysteine was present in the media.
Discussion
The list of new compounds and agents to which the
lungs are subjected is enormous, yet, in very few cases
have studies been made on the interactions between
theseagentsandthelungs. Inthisstudywehavedescrib-
edanexperimentalmethodformeasuringtheeffectsof
potential pulmonary toxins on the lungs, and we have
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FIGURE 5. Theeffectofacrolein concentration ontheincorporation
of '4C-leucine intoproteinbyslices. Eachvalueisthe meanoftwo
determinations. Range values shown by vertical lines.
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FIGURE6. The effect of various concentrations of acrolein (U = 0.17
mM; 0 = 0.36 mM; A = 0.89 mM) on the rate of incorporation of
'4C-leucine into protein by lung slices (. = control).
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Fi(,GJRE 7. The effect of acrolein on the incorporation of 14C-leucine
over3hrintheabsence(O)and presence(n=)ofN-acetylcysteine.
TheacroleinandN-acetylcysteine werepresentintheprein-
cubation only. Each value is the mean of two determina-
tions. Range values are shown by vertical lines.
demonstratedthatproteinbiosynthesisbylungslices can
be used as a valuable indicator of the interactions be-
tween chemicals and pulmonary metabolism. It was
shown that two known inhibitors of protein synthesis,
ricin and cycloheximide, were potent inhibitors at low
concentrations and, furthermore, that ricin inhibition
was dose dependent.
Inallexperimentsinvolvingdrugs astestcompounds,
the concentration ranges were compiled from the dose
regimes used clinically. It is noteworthy that quite
different results were obtained with the nonselective
P-receptor stimulants isoprenaline and orciprenaline.
Although orciprenaline was used at approximately 10
timestheconcentrationofisoprenaline, thedrughad no
adverse effects on protein biosynthesis, and the
enhancement of 14C-leucine incorporation was re-
corded at all concentrations of the drug. By contrast,
isoprenaline wasinhibitory atthehigherconcentrations
used. Neitherterbutaline norsalbutamol wasinhibitory,
and, as with orciprenaline, stimulation of '4C-leucine
incorporation was recorded at some dose levels. Beta-
methasone, a glucocorticoid, on the other hand, show-
edabiphasicaction; atthelowestdosagetheincorpora-
tion levels were significantly enhanced while at the
highest dosages there was more than 50% inhibition.
Collectively, the results obtained with drugs used
clinically illustrate that some drugs have no adverse
effects on the numerous biochemical transformations
culminating in amino acid assembly, while others are
markedly inhibitory. In the case of inhibitory drugs, a
numberofnewavenuesareopened. Forexample, itmay
beimportanttodeterminewhetherinhibition ofprotein
synthesis is selective or not. The possibility is also
presented of modifying the drug structure so that
therapeuticpotencyispreserved butinhibitoryproper-
ties are abolished.
Theinvolvementofcigarettesmokeinlungdiseasehas
beenmuchstudied, andseveralworkershavequestion-
edthesignificance oftheacroleincontentofsmoke(8).
Inthisstudywereporttheinhibitoryeffectsofboththe
aqueous extract of cigarette smoke and acrolein in the
synthesisofprotein, andthedose regime waschosento
be inthe same range as that present in cigarette smoke
[-4.1 tig acrolein/10 mL filtred smoke (8)]. Acrolein
is a well-known cytotoxin that is widely distributed in
biological material (9). In an early study Willmer and
Walersteiner (10) showed that various aldehydes in-
hibitedgrowthandcellularactivityintheconcentration
region of2 mM. However, acrolein produced similar in-
hibitoryeffectsatconsiderablylowerconcentrations(20
uM). In addition to the importance of the presence of
acrolein in cigarette smoke, this aldehyde is widely us-
ed in industry as a synthetic intermediate and is evolv-
ed during the overheating of biological material (11).
Acrolein has also been shown to be the ultimate
metabolite responsible for the observed toxicity of
several compounds including endogenous polyamines,
spermine, and spermidine (12) that are ubiquitous in
animaltissues(13), andallylalcohol(14). Recentstudies
implicate acroleintobeamediatorofthepulmonary(15)
and renal (16) toxicity of cyclophosphamide that is ex-
tensively used in therapy as an antineoplastic and im-
munosuppressive agent. Ithasalsobeensuggestedthat
the antineoplastic effects of spermine (17) and
cyclophosphamide(18)maybe, inpart, duetothelibera-
tion of acrolein in situ. Thus, the inhibitory effect of
acrolein on proteinbiosynthesis may have far-reaching
significance. Aswiththecompoundsdiscussedprevious-
ly, it may well be important to study the specificity of
action with respect to the synthesis and the half-lives
of proteins whose synthesis is affected.
Attempts have been made to relate the effects of
aqueouscigarettesmokeandacroleinontheincorpora-
tion of amino acids into alveolar macrophage protein,
and it has beensuggested(8)that the effects are quan-
titatively and qualitatively different. However, ex-
perience inthepresentinvestigationsuggeststhatgreat
care must be exercised in interpreting the effects of
acrolein at low concentrationsbecause ofthe volatility
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andinstability ofthealdehyde. Alsowhenevaluatingthe
effects ofacrolein intermsofitsaffinity for-SHgroups,
by experiments in the presence ofN-acetylcysteine, it
isessentialthatN-acetylcysteine isaddedbeforeacrolein
becausetheeffects ofacroleinarenotreversible. Itmay
well be that conflicting reports on protection from
acroleinbyN-acetylcysteine (19,20)canbeexplainedin
terms of the experimental protocol. A preliminary ac-
countofthepresentworkhasbeenpresentedpreviously
(21).
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